Within-trial evaluation of medical resources, costs, and quality of life among patients with type 2 diabetes participating in the exenatide study of cardiovascular event lowering (EXSCEL) (Diabetes Care, 2019)

(untitled) - Reed, S; Li, Y; Dakin, H; Becker, F; Leal, J; Gustavson, S; Kartman, B; Wittbrodt, E; Mentz, R; Pagidipati, N; Bethel, M; Gray, A; et al.